| |||
| |||
| Names | |||
|---|---|---|---|
| Preferred IUPAC name
2-(2,5-Dimethoxy-3,4-dimethylphenyl)ethan-1-amine | |||
| Identifiers | |||
3D model (JSmol) |
|||
| ChEMBL | |||
| ChemSpider |
| ||
PubChem CID |
|||
| UNII | |||
CompTox Dashboard (EPA) |
|||
| |||
| |||
| Properties | |||
| C12H19NO2 | |||
| Molar mass | 209.289 g·mol−1 | ||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |||
2C-G is a psychedelic phenethylamine of the 2C-series. First synthesizedbyAlexander Shulgin,[1] it is sometimes used as an entheogen. It has structural and pharmacodynamic properties similar to 2C-D and Ganesha. Like many of the phenethylamines in PiHKAL, 2C-G and its homologs have only been taken by Shulgin and a small test group, making it difficult to ensure completeness when describing effects.
2C-G is 3,4-dimethyl-2,5-dimethoxyphenethylamine, with the formula C
12H
19NO
2.
In Shulgin's book PiHKAL, the dosage range is listed as 20 to 35 mg.[1] Effects are similar to the related Ganesha, and are extremely long lasting; the duration is 18–30 hours. Visual effects are muted or absent, and it is described in PiHKAL as an "insight-enhancer".[1] Unlike other members of the 2C-series, 2C-G is nearly as potent as its amphetamine form.
Several homologs of 2C-G were also synthesized by Shulgin. These include 2C-G-3, 2C-G-5, and 2C-G-N. Some, such as 2C-G-1, 2C-G-2, 2C-G-4, and 2C-G-6 are possible to synthesize in principle but impossible or extraordinarily difficult to do so in practice.
| 2C-G-1 | CAS: 2888537-47-9 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 |
 |
| 2C-G-2 | CAS: 2888537-48-0 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 |
 |
| 2C-G-3 | CAS: 207740-19-0
Dosage: 16–25 mg |
 |
| 2C-G-4 | CAS: 952006-59-6 Synthesized but not tested. |
 |
| 2C-G-5 | CAS: 207740-20-3
Dosage: 10–16 mg |
 |
| 2C-G-6 | CAS: 2888537-49-1 The synthesis of this compound has not been reported, but it is described prophetically in WO2022271982 |
 |
| 2C-G-N | CAS: 207740-21-4
Dosage: 20–40 mg |
 |
As of October 31, 2016; 2C-G is a controlled substance (Schedule III) in Canada.[2]
2C-G and all other compounds featuring in PiHKAL are Class A drugs in the United Kingdom.
In the United States 2C-G is considered a Schedule 1 controlled substance as a positional isomer of 2C-E and 2,5-Dimethoxy-4-methylamphetamine (DOM).[3]
